Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

Barclays analyst Benjamin Budish lowered the firm’s price target on KKR (KKR) to $181 from $185 and keeps an Overweight rating on the shares ...

Citi analyst Christopher Allen reiterated a Buy rating on KKR & Co (KKR – Research Report) today. The company’s shares closed yesterday at ...

Q4 2024 Earnings Call Transcript February 4, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.32, expectations were $1.3. Operator: Ladies and gentlemen, thank you for standing by.

KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...

Tech groups and clean power builders are partnering to co-locate data centers and power generation to reduce permitting and ...

KKR & Co's fourth-quarter assets under management fell short of expectations on Tuesday, dampening the optimism ...

Chakravarthy made a comeback to the Indian unit in the home series against Bangladesh in October 2024 and is the leading ...

IPL 2025: Sunil Narine, one of the biggest one-team legends in the history of Indian Premier League, was signed by Kolkata ...

KKR & Co. (KKR) stock drew retail attention on Tuesday after its fourth-quarter earnings topped Wall Street estimates. The ...

The media group Semafor has visions for creating an economic forum for the United States that rivals the annual event in ...